Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2026)

Sunshine Biopharma has reported Change in Inventory for 9 years, with the latest figure at -$78399.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 113.78% year-over-year to -$78399.0; the trailing twelve-month figure through Mar 2026 stood at $990044.0 (down 77.88% YoY), and the FY2025 full-year result was $1.6 million, down 72.74% from the prior year.
• Change in Inventory for Q1 2026 stood at -$78399.0, up from -$772796.0 in the prior quarter.
• The five-year high for Change in Inventory was $2.1 million in Q1 2024, with the low at -$772796.0 in Q4 2025.
• Historically, Change in Inventory has averaged $581665.2 across 5 years, with a median of $467925.0 in 2023.
• The largest YoY upside for Change in Inventory was 2456.77% in 2022 against a maximum downside of 702.72% in 2022.
• Sunshine Biopharma's Change in Inventory stood at -$206974.0 in 2022, then jumped by 652.94% to $1.1 million in 2023, then soared by 57.71% to $1.8 million in 2024, then sank by 142.82% to -$772796.0 in 2025, then jumped by 89.86% to -$78399.0 in 2026.
• The last three Change in Inventory figures came in at -$78399.0 (Q1 2026), -$772796.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.